Viseslav Popadic

Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Cardiovascular Magnetic Resonance in Detecting Cardiovascular Involvement in Systemic Inflammatory Disease: Focus on Inflammatory Bowel Disease, Obesity, and Systemic Sclerosis.

Cardiovascular Magnetic Resonance in Detecting Cardiovascular Involvement in Systemic Inflammatory Disease: Focus on Inflammatory Bowel Disease, Obesity, and Systemic Sclerosis.

Journal: Magnetic resonance imaging clinics of North America

Published: April 19, 2026

Breast Cancer and Cardiovascular Risk: The Role of Dyslipidemia, Inflammation and Obesity.

Breast Cancer and Cardiovascular Risk: The Role of Dyslipidemia, Inflammation and Obesity.

Journal: Diagnostics (Basel, Switzerland)

Published: September 01, 2025

Can Galectin-3 Be Used as a Predictor of Obstructive Sleep Apnea Severity: Insights from High-Volume Patient Single Center.

Can Galectin-3 Be Used as a Predictor of Obstructive Sleep Apnea Severity: Insights from High-Volume Patient Single Center.

Journal: Diagnostics (Basel, Switzerland)

Published: November 21, 2024

Contemporary Diagnostics of Cardiac Sarcoidosis: The Importance of Multimodality Imaging.

Contemporary Diagnostics of Cardiac Sarcoidosis: The Importance of Multimodality Imaging.

Journal: Diagnostics (Basel, Switzerland)

Published: July 29, 2024

The Correlation between Cardiac Magnetic Resonance Findings and Post-COVID-19: The Impact of Myocardial Injury on Quality of Life.

The Correlation between Cardiac Magnetic Resonance Findings and Post-COVID-19: The Impact of Myocardial Injury on Quality of Life.

Journal: Diagnostics (Basel, Switzerland)

Published: July 21, 2024

The silent predictors: exploring galectin-3 and Irisin's tale in severe COVID-19.

The silent predictors: exploring galectin-3 and Irisin's tale in severe COVID-19.

Journal: BMC research notes

Published: April 24, 2024

New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk.

New Therapeutic Approaches for the Treatment of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Increased Cardiovascular Risk.

Journal: Diagnostics (Basel, Switzerland)

Published: December 14, 2023

Coronary Microvascular Dysfunction and Hypertension: A Bond More Important than We Think.

Coronary Microvascular Dysfunction and Hypertension: A Bond More Important than We Think.

Journal: Medicina (Kaunas, Lithuania)

Published: November 13, 2023

Galectin-3 as a Prognostic Biomarker in Patients with First Acute Myocardial Infarction without Heart Failure.

Galectin-3 as a Prognostic Biomarker in Patients with First Acute Myocardial Infarction without Heart Failure.

Journal: Diagnostics (Basel, Switzerland)

Published: September 20, 2023

The Predictive Value of Risk Factors and Prognostic Scores in Hospitalized COVID-19 Patients.

The Predictive Value of Risk Factors and Prognostic Scores in Hospitalized COVID-19 Patients.

Journal: Diagnostics (Basel, Switzerland)

Published: June 27, 2023

The emergence of multi-drug-resistant bacteria causing healthcare-associated infections in COVID-19 patients: a retrospective multi-centre study.

The emergence of multi-drug-resistant bacteria causing healthcare-associated infections in COVID-19 patients: a retrospective multi-centre study.

Journal: The Journal of hospital infection

Published: March 14, 2023

Incidence and Risk Factors for Clostridioides difficile Infections in Non-COVID and COVID-19 Patients: Experience from a Tertiary Care Hospital.

Incidence and Risk Factors for Clostridioides difficile Infections in Non-COVID and COVID-19 Patients: Experience from a Tertiary Care Hospital.

Journal: Microorganisms

Published: January 13, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026